A097: Mucosal healing in IBD: deciphering the role of STAT3 activation in intestinal mesenchymal cell populations
FAU own research funding: EFI / IZKF / EAM ...
Start date :
01.07.2023
End date :
31.12.2025
p21 Prevents the Exhaustion of CD4+ T Cells Within the Antitumor Immune Response Against Colorectal Cancer (2024)
Thoma OM, Naschberger E, Kubánková M, Larafa I, Kramer V, Menchicchi B, Merkel S, et al.
Journal article
Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center. (2023)
Tögel L, Schubart C, Lettmaier S, Neufert C, Hoyer J, Wolff K, Moskalev E, et al.
Journal article
NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases (2023)
Weber S, Sitte S, Vögele AL, Sologub L, Wilfer A, Rath T, Nägel A, et al.
Journal article
Novel T cell/organoid culture system allows ex vivo modeling of intestinal graft-versus-host disease (2023)
Matthe D, Dinkel M, Schmid B, Vogler T, Neurath M, Poeck H, Neufert C, et al.
Journal article
Protective effect of the novel calcineurin inhibitor voclosporin in experimental colitis (2023)
Lindemann A, Roth D, Koop K, Neufert C, Zundler S, Atreya R, Neurath M, Leppkes M
Journal article
Interleukin 36 receptor-inducible matrix metalloproteinase 13 mediates intestinal fibrosis (2023)
Koop K, Enderle K, Hillmann M, Ruspeckhofer L, Vieth M, Sturm G, Trajanoski Z, et al.
Journal article